Next Arc Research

Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author holds a long position in AMPX.
← Back to Free Index

AMPX

Analysis as of: 2026-05-14
Amprius Technologies, Inc.
Amprius develops and sells high-energy silicon-anode lithium-ion batteries for drones, aviation, defense and other mobility applications.
aerospace defense energy hardware transportation
On Yahoo Finance ...
Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

Premium Cells Need Scaled Trust
The company has a real battery-performance edge in weight-sensitive applications and a credible path into defense, drones and aviation. The five-year upside now depends less on chemistry discovery and more on whether trusted supply, partner execution and repeat orders can justify today’s rich starting valuation.

Analysis

Thesis
Amprius has a real performance edge in weight-sensitive batteries and a credible capital-light path to scale; if it converts NDAA-aligned supply, partner manufacturing and module-level upsell into repeat defense, drone and mobility programs, revenue can grow non-linearly even though the stock still needs heavy multiple compression to work.
Last Economy Alignment
AI should expand drones, robotics and autonomous systems that need lighter batteries; Amprius benefits, but it still does not fully control scaled supply.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
2.0x (from 5 most recent analyses)
Reasoning
The business can outgrow the stock. Amprius has enough technical differentiation and end-market pull to plausibly scale fast in drones, defense, aerospace and select mobility, especially if it moves some value capture from cells into modules, compliance-ready supply and data-backed support. But today’s valuation already prices in a lot of chemistry success, so even a strong operating outcome likely comes with a lower sales multiple by 2031.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The main risk is not whether the cells work; it is whether Amprius can turn chemistry leadership into durable, repeatable, compliant scale before competitors, suppliers or valuation compression take the economics away. The binding gates are NDAA-compliant sourcing, U.S. partner qualification, Berzelius dependence, and proof that repeat orders can build faster than dilution or multiple compression.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Last Economy Structure

AI Industrial Score
0.47
They sell lighter, longer-lasting batteries into drones and defense systems that AI makes more useful, so rising autonomy can create real demand. Their edge comes from trusted supply, qualification know-how and performance, but bigger battery makers and sourcing rules can still squeeze them if scale slips.
Upgrade to Reader to also access: Score Decomposition, Confidence Level
Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility
Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target
$19.75
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case